HSF1

Heat Shock Factor 1 (HSF1) functions as a master transcriptional regulator, maintaining cellular proteostasis under stress conditions^[1][2]. Mechanistically, HSF1 activation induces heat shock proteins (HSPs), which assist in protein folding, prevent misfolding, and modulate apoptosis pathways^[3][2][1]. In metabolic contexts, HSF1 regulates lipid homeostasis through the HSF1-CPT1a axis, influencing hepatic fat accumulation in non-alcoholic fatty liver disease (NAFLD) models^[4]. Compared with other isoforms, HSF1 specifically activates transcriptional networks distinct from HSP-independent stress responses, including the FOXO3a-ΔNp63α-CDK4 axis in head and neck squamous cell carcinoma (HNSCC)^[5]. In pediatric hepatoblastoma, elevated HSF1 correlates with tumor aggressiveness and decreased differentiation, while its inhibition induces apoptosis and reduces tumor growth^[6]. Pharmacological modulation of HSF1, either through activators or inhibitors, demonstrates potential for experimental applications: inhibitors such as KRIBB11 or PU-H71 can suppress HSF1-dependent pathways, decreasing proliferation in cancer models, whereas HSF1 activation enhances inducible HSP expression in neurodegeneration studies^[2][1][5][6]. The differential roles of HSF1 in disease versus normal physiology underscore its value as a target for isoform-specific drug development, enabling selective modulation of stress response pathways without broadly affecting related transcription factors^[1][2][7]. Therefore, HSF1 serves as both a critical mechanistic node in cellular stress adaptation and a strategic intervention point for disease modeling and therapeutic exploration^[1][5][6].